Capricor Therapeutics Inc Cash Flow-to-Debt Ratio
Capricor Therapeutics Inc cash flow-to-debt ratio. Capricor Therapeutics Inc (CAPR) has a Cash Flow-to-Debt Ratio of -0.61x as of March 2026, meaning its operating cash flow of $-29.25 Million could theoretically repay -1% of its total liabilities ($47.58 Million) in one year. Check Capricor Therapeutics Inc (CAPR) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Capricor Therapeutics Inc (1999–2025)
Cash flow-to-debt ratio of Capricor Therapeutics Inc from 1999 to 2025. Historical debt coverage capacity for Capricor Therapeutics Inc across 27 annual periods. Check cash flow reinvestment rate of Capricor Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Capricor Therapeutics Inc Cash Flow-to-Debt Ratio by Year (1999–2025)
Capricor Therapeutics Inc cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for Capricor Therapeutics Inc. For the full cash flow conversion analysis, see CAPR cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.39x | $-69.81 Million | $50.16 Million | ▲ +12.9% |
| 2024 | -1.60x | $-40.00 Million | $25.02 Million | ▼ -125.7% |
| 2023 | -0.71x | $-25.60 Million | $36.13 Million | ▼ -652.0% |
| 2022 | 0.13x | $4.92 Million | $38.31 Million | ▲ +107.6% |
| 2021 | -1.69x | $-16.81 Million | $9.96 Million | ▼ -7.7% |
| 2020 | -1.57x | $-10.05 Million | $6.42 Million | ▲ +1.9% |
| 2019 | -1.60x | $-6.82 Million | $4.27 Million | ▲ +46.7% |
| 2018 | -2.99x | $-13.86 Million | $4.63 Million | ▼ -6.1% |
| 2017 | -2.82x | $-14.23 Million | $5.05 Million | ▼ -306.0% |
| 2016 | -0.69x | $-15.80 Million | $22.75 Million | ▼ -9.8% |
| 2015 | -0.63x | $-10.82 Million | $17.10 Million | ▼ -1411.9% |
| 2014 | 0.05x | $958.56K | $19.88 Million | ▲ +104.8% |
| 2013 | -1.01x | $-6.14 Million | $6.07 Million | ▲ +75.5% |
| 2012 | -4.13x | $-2.19 Million | $529.17K | ▲ +51.9% |
| 2011 | -8.59x | $-4.65 Million | $541.45K | ▼ -112.6% |
| 2010 | -4.04x | $-4.32 Million | $1.07 Million | ▲ +55.6% |
| 2009 | -9.09x | $-5.80 Million | $637.55K | ▼ -13.8% |
| 2008 | -7.99x | $-10.64 Million | $1.33 Million | ▼ -180.9% |
| 2007 | -2.84x | $-5.37 Million | $1.89 Million | ▼ -589.3% |
| 2006 | -0.41x | $-55.60K | $134.78K | ▼ -80.6% |
| 2005 | -0.23x | $-17.79K | $77.91K | ▲ +12.4% |
| 2004 | -0.26x | $-15.48K | $59.40K | ▲ +47.7% |
| 2003 | -0.50x | $-20.82K | $41.77K | ▲ +14.5% |
| 2002 | -0.58x | $-14.32K | $24.55K | ▲ +58.9% |
| 2001 | -1.42x | $-13.02K | $9.19K | ▲ +96.6% |
| 2000 | -41.47x | $-37.32K | $900.00 | ▼ -4046.9% |
| 1999 | -1.00x | $-900.00 | $900.00 | — |